Results

Krystal Biotech Inc.

06/22/2022 | Press release | Distributed by Public on 06/22/2022 05:06

Krystal Biotech Submits Biologics License Application to U.S. FDA Seeking Approval of B-VEC for the Treatment of Patients with Dystrophic Epidermolysis Bullosa